global elite pharmaceutical distribution inc.

897 front street
uniondale, new york 11553

NYS Entity Status
ACTIVE

NYS Filing Date
JANUARY 15, 2014

NYS DOS ID#
4513872

County
NASSAU

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2014 - GLOBAL ELITE PHARMACEUTICAL DISTRIBUTION INC.









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • A Drug Maker Spends Big in Washington to Make Itself Heard
    By JAY HANCOCK, ELIZABETH LUCAS and SYDNEY LUPKIN - Friday Jul 21, 2017

    Mallinckrodt’s spending on political donations and lobbying comes as the drug industry as a whole beefs up its Capitol Hill presence.

    Source: NYT > Home Page
  • Impax Laboratories and Amneal Pharmaceuticals Near Merger Agreement
    Monday Oct 16, 2017

    Impax Laboratories Inc. and Amneal Pharmaceuticals LLC are close to agreement on a merger that would create the nation’s fifth-largest generic-drug company by revenue, according to people familiar with the matter.

    Source: The Wall Street Journal: U.S. Business
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York
  • Considering the Side Effects of Drugmakers’ Money-Back Guarantees
    By KATIE THOMAS and CHARLES ORNSTEIN - Monday Jul 10, 2017

    The Trump administration is considering encouraging lowering drug costs through outcome-based contracts, but there is little evidence the approach works.

    Source: NYT > Home Page
  • Amid Opioid Crisis, Insurers Restrict Pricey, Less Addictive Painkillers
    By KATIE THOMAS and CHARLES ORNSTEIN - Monday Sep 18, 2017

    Drug companies and doctors have been accused of fueling the opioid crisis, but some question whether insurers have played a role, too.

    Source: NYT > Home Page